Your trusted source for investing success

Tag: emblem corp

Looking for Cannabis Stocks?

Read our report to find market data, important news and stocks to watch!
Emblem Announces Exclusive Agreement with Canntab Therapeutics for Cannabinoid Based Oral Sustained Release Formulation

Emblem Announces Exclusive Agreement with Canntab Therapeutics for Cannabinoid Based Oral Sustained Release Formulation

Emblem Corp. (TSXV:EMC) (EMC.WT) (“Emblem” or the “Company”) announced today that it has entered into a Collaboration and Licensing Agreement (the “Agreement”) with Canntab Therapeutics Limited (“Canntab”) of Toronto. Canntab has developed a patent-pending oral sustained release formulation for cannabinoids (the “Sustained Release Product” or the “Product”). Under the Agreement,

Emblem Sees Significant Rise in Patient Acquisition

Emblem Corp. (TSXV:EMC) (“Emblem” or the “Company”) is pleased to announce that the Company has successfully ramped up its patient acquisition program resulting in a total of 2,091 active and pending patients (net of expired and disabled registrations) having registered since the opening of its patient fulfillment website in late

Emblem Corp. Announces Retainer of Nate Nienhuis

PARIS, ONTARIO–(Marketwired – March 10, 2017) – Emblem Corp. (TSX VENTURE:EMC) (“Emblem” or the “Company”) is pleased to announce that it has retained the consulting services of Nate Nienhuis for its Canadian cannabis operations.

Emblem Enters into MOU with ICC International Cannabis

Emblem (TSXV:EMC) has entered into a non-binding memorandum of understanding with ICC International Cannabis (TSXV:ICC), a licensed producer out of Uruguay.

As quoted in the press release:
Subject to finalizing a definitive agreement and applicable regulatory approvals, including but not limited to those from the IRCCA, the Uruguayan Ministry of Livestock, Agriculture

Emblem Corp. Announces $10 Million Special Warrant Bought Deal Financing

Emblem Corp. (the “Company”) (TSX VENTURE:EMC) announces that is has entered into an engagement letter with PI Financial Corp., on behalf of a syndicate of underwriters, (collectively, the “Underwriters”) pursuant to which the Underwriters have agreed to purchase 2,754,821 special warrants of the Company (the “Special Warrants”) on an underwritten

New Competitor in MMJ Market sets High Standards

PI Financial is initiating coverage of Emblem (TSXV:EMC) with a BUY rating (Risk rating: SPECULATIVE) with a 12-month target of $3.25.

As quoted in the report:
Emblem Corp. is a fully integrated Canadian medical marijuana, healthcare and cannabinoid-based pharmaceutical company licensed to carry on business as a producer and seller of medical

Emblem Corp. Provides Update on Qualifying Transaction

Emblem Corp. (the “Company”) (TSXV:EMC), formerly Saber Capital Corp. (TSX VENTURE:SAB:H), announces the following updates in respect of its previously announced qualifying transaction (the “Qualifying Transaction”) with 9045538 Canada Inc. (formerly Emblem Corp.).

10+ Gold Stocks to Watch

Expert Insights.
Industry Stats.

Give me my free report!
Enter Your Log In Credentials
This setting should only be used on your home or work computer.


Privacy & Legal Policy

Privacy Policy

Investing News Network

Send this to a friend

I thought you might find this interesting:
Cannabis Weekly Round-Up: Two Provinces Reveal Deals in Place for Recreational Market